Literature DB >> 23203849

Psychosocial factors and uptake of risk-reducing salpingo-oophorectomy in women at high risk for ovarian cancer.

Bettina Meiser1, Melanie A Price, Phyllis N Butow, Janan Karatas, Judy Wilson, Louise Heiniger, Brandi Baylock, Margaret Charles, Sue-Anne McLachlan, Kelly-Anne Phillips.   

Abstract

Bilateral risk-reducing salpingo-oophorectomy (RRSO) has been shown to significantly reduce the risk of ovarian cancer. This study assessed factors predicting uptake of RRSO. Women participating in a large multiple-case breast cancer family cohort study who were at increased risk for ovarian and fallopian tube cancer (i.e. BRCA1 or BRCA2 mutation carrier or family history including at least one first- or second-degree relative with ovarian or fallopian tube cancer), with no personal history of cancer and with at least one ovary in situ at cohort enrolment, were eligible for this study. Women who knew they did not carry the BRCA1 or BRCA2 mutation segregating in their family (true negatives) were excluded. Sociodemographic, biological and psychosocial factors, including cancer-specific anxiety, perceived ovarian cancer risk, optimism and social support, were assessed using self-administered questionnaires and interviews at cohort enrolment. RRSO uptake was self-reported every three years during systematic follow-up. Of 2,859 women, 571 were eligible. Mean age was 43.3 years; 62 women (10.9 %) had RRSO a median of two years after cohort entry. Factors predicting RRSO were: being parous (OR 3.3, p = 0.015); knowing one's mutation positive status (OR 2.9, p < 0.001) and having a mother and/or sister who died from ovarian cancer (OR 2.5, p = 0.013). Psychological variables measured at cohort entry were not associated with RRSO. These results suggest that women at high risk for ovarian cancer make decisions about RRSO based on risk and individual socio-demographic characteristics, rather than in response to psychological factors such as anxiety.

Entities:  

Mesh:

Year:  2013        PMID: 23203849     DOI: 10.1007/s10689-012-9585-8

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  27 in total

Review 1.  Optimistic biases about personal risks.

Authors:  N D Weinstein
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

2.  Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer.

Authors:  B Meiser; P Butow; M Friedlander; V Schnieden; M Gattas; J Kirk; G Suthers; E Haan; K Tucker
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

3.  The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.

Authors:  Joanna B Madalinska; Marc van Beurden; Eveline M A Bleiker; Heiddis B Valdimarsdottir; Judith Hollenstein; Leon F Massuger; Katja N Gaarenstroom; Marian J E Mourits; René H M Verheijen; Eleonora B L van Dorst; Hans van der Putten; Ko van der Velden; Henk Boonstra; Neil K Aaronson
Journal:  J Clin Oncol       Date:  2006-08-01       Impact factor: 44.544

4.  The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews.

Authors:  M B Hatcher; L Fallowfield; R A'Hern
Journal:  BMJ       Date:  2001-01-13

5.  Decision-making process of women carrying a BRCA1 or BRCA2 mutation who have chosen prophylactic mastectomy.

Authors:  Megan McQuirter; Luisa Luciani Castiglia; Carmen G Loiselle; Nora Wong
Journal:  Oncol Nurs Forum       Date:  2010-05       Impact factor: 2.172

6.  Optimism, coping, and health: assessment and implications of generalized outcome expectancies.

Authors:  M F Scheier; C S Carver
Journal:  Health Psychol       Date:  1985       Impact factor: 4.267

Review 7.  Psychological impact of genetic testing for cancer susceptibility: an update of the literature.

Authors:  Bettina Meiser
Journal:  Psychooncology       Date:  2005-12       Impact factor: 3.894

8.  Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing.

Authors:  Marc D Schwartz; Elizabeth Kaufman; Beth N Peshkin; Claudine Isaacs; Chanita Hughes; Tiffani DeMarco; Clinton Finch; Caryn Lerman
Journal:  J Clin Oncol       Date:  2003-11-01       Impact factor: 44.544

9.  Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.

Authors:  B Meiser; P Butow; M Price; B Bennett; G Berry; K Tucker
Journal:  J Womens Health (Larchmt)       Date:  2003-10       Impact factor: 2.681

10.  Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers.

Authors:  Angela R Bradbury; Comfort N Ibe; James J Dignam; Shelly A Cummings; Marion Verp; Melody A White; Grazia Artioli; Laura Dudlicek; Olufunmilayo I Olopade
Journal:  Genet Med       Date:  2008-03       Impact factor: 8.822

View more
  7 in total

1.  Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study.

Authors:  Phuong L Mai; Marion Piedmonte; Paul K Han; Richard P Moser; Joan L Walker; Gustavo Rodriguez; John Boggess; Thomas J Rutherford; Oliver Zivanovic; David E Cohn; J Tate Thigpen; Robert M Wenham; Michael L Friedlander; Chad A Hamilton; Jamie Bakkum-Gamez; Alexander B Olawaiye; Martee L Hensley; Mark H Greene; Helen Q Huang; Lari Wenzel
Journal:  Gynecol Oncol       Date:  2017-02-10       Impact factor: 5.482

2.  Timing and context: important considerations in the return of genetic results to research participants.

Authors:  Kate A McBride; Nina Hallowell; Martin H N Tattersall; Judy Kirk; Mandy L Ballinger; David M Thomas; Gillian Mitchell; Mary-Anne Young
Journal:  J Community Genet       Date:  2015-05-26

3.  Intuition versus cognition: a qualitative exploration of how women understand and manage their increased breast cancer risk.

Authors:  Louise Heiniger; Phyllis N Butow; Margaret Charles; Melanie A Price
Journal:  J Behav Med       Date:  2015-03-28

4.  Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer.

Authors:  Bettina Meiser; Melanie A Price; Phyllis N Butow; Belinda Rahman; Kathy Tucker; Benjamin Cheah; Adrian Bickerstaffe; John Hopper; Kelly-Anne Phillips
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

Review 5.  The role of emotions in cancer patients' decision-making.

Authors:  Ketti Mazzocco; Marianna Masiero; Maria Chiara Carriero; Gabriella Pravettoni
Journal:  Ecancermedicalscience       Date:  2019-03-28

Review 6.  Emotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancer.

Authors:  Cara Stabile; Abigail Gunn; Yukio Sonoda; Jeanne Carter
Journal:  Transl Androl Urol       Date:  2015-04

7.  The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy.

Authors:  Jessica E van der Aa; Jacob P Hoogendam; Els S F Butter; Margreet G E M Ausems; René H M Verheijen; Ronald P Zweemer
Journal:  Fam Cancer       Date:  2015-12       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.